Kalkine: ASX 200 Stocks on Sale: CSL, SMR, CIA, NXT, YAL Facing Deep Declines

June 03, 2025 10:36 PM PDT | By Team Kalkine Media
 Kalkine: ASX 200 Stocks on Sale: CSL, SMR, CIA, NXT, YAL Facing Deep Declines
Image source: shutterstock

Highlights

  • CSL (ASX:CSL), a healthcare leader, sees share pressure amid global pricing reforms

  • Resource firms SMR (ASX:SMR), CIA (ASX:CIA), and YAL (ASX:YAL) impacted by falling commodity prices

  • Tech player NXT (ASX:NXT) focuses on expansion despite recent share weakness

Several major names within the ASX 200 index are trading well below their previous levels, with share price declines extending across both this calendar year and the past twelve months. Each of these companies operates within a core segment of the Australian market, including healthcare, mining, and technology. Despite downtrends in stock movement, institutional sentiment remains supportive for some.

Stanmore Resources Limited (ASX:SMR)
Stanmore Resources operates in the coal sector and has seen shares decline significantly throughout the year. Recent production updates show output and sales tracking above forecasts, yet debt levels have risen due to coal price declines and adverse weather conditions in Queensland. These factors have influenced the company’s capital planning, with certain projects delayed. Dividend returns continue to draw attention within the sector.

Champion Iron Limited (ASX:CIA)
Champion Iron, a Canadian iron ore producer listed on the ASX, continues to face downward pressure linked to lower iron ore prices. Recent earnings metrics show steady revenue and EBITDA figures, although net income has dropped compared to the previous year. The business has advanced development on its DRPF plant and announced a dividend that exceeded projections. Industry commentary still references the stock within long-term planning contexts.

CSL Limited (ASX:CSL)
CSL, a prominent global healthcare provider, has experienced a moderate decline in its share price. Challenges impacting its performance include uncertainty tied to US drug pricing frameworks and Medicare adjustments. Despite these issues, its immunoglobulin product line remains a primary driver, showing ongoing growth. Industry coverage has noted CSL’s resilience in responding to external pressures and navigating operational complexity.

NextDC Limited (ASX:NXT)
NextDC, a key player in data centre infrastructure across Australia, has faced slowing momentum in its share valuation. Capital-intensive expansion projects have not translated into immediate revenue growth. However, analysts monitoring the sector note that its contracted power supply is already aligned with medium-term growth projections. Recent public equity strategies have included NXT as a component in technology-focused allocations.

Yancoal Australia Limited (ASX:YAL)
Yancoal, a major coal producer, has been weighed down by a broad decline in coal prices and a sizable tax-related charge. These factors have significantly affected recent profitability. Nevertheless, the company maintains a sizeable reserve for acquisitions, with future interests possibly extending beyond domestic markets and even beyond the coal segment itself.

Each of these companies reflects wider economic and commodity cycles, with movements influenced by global pricing dynamics, sector-specific regulation, and strategic investment plans.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next